Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
UTAH MEDICAL PRODUCTS INC
Bear Case (25th pct.)
5.9% vs price
Base Case (Median)
15.3% vs price
Bull Case (75th pct.)
40.1% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $119.91 | 78.5% | High (40%) |
| PE Comparable | $74.56 | 11.0% | Medium (25%) |
| Graham Number | $52.58 | -21.7% | Medium (40%) |
| EV/EBITDA | $80.36 | 19.7% | Medium (20%) |
| EV/FCF | $98.68 | 46.9% | Medium (20%) |
| Earnings Power Value | $69.96 | 4.2% | Medium (50%) |
Based on 6 out of 7 methods, UTMD appears undervalued at the current price of $67.16. The base case fair value of $77.46 implies 15.3% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.